Can fibrate therapy redefine the management of diabetic retinopathy? A comprehensive systematic review and meta-analysis of efficacy and safety
Authors:
Top Cited Papers
- 27 September 2025
- journal article
- review article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 39 (11) , 109178
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic RetinopathyJAMA Ophthalmology, 2022
- Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trialDiabetologia, 2021
- Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with DiabetesAmerican Journal of Ophthalmology, 2019
- Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedemaCochrane Database of Systematic Reviews, 2018
- Fenofibrate and Diabetic RetinopathyCurrent Diabetes Reports, 2016
- The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 DiabetesOphthalmology, 2014
- Meta-Analysis of Safety of the Coadministration of Statin With Fenofibrate in Patients With Combined HyperlipidemiaThe American Journal of Cardiology, 2012
- More Clinical Lessons from the FIELD StudyCardiovascular Drugs and Therapy, 2009
- Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and MethodsThe American Journal of Cardiology, 2007
- Association of Elevated Serum Lipid Levels With Retinal Hard Exudate in Diabetic RetinopathyArchives of Ophthalmology (1950), 1996